This manuscript by Yamanashi et al retrospectively looks into the outcome of patients with newly classified clinical T4 lung cancer. They report 93 patients who underwent surgical treatment during a 10-year study period. They identified several risk factors and conclude that “surgery should be considered if there is no suspicion of N2 disease and complete resection is technically feasible.”